Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D02DKM
|
||||
Former ID |
DNC010412
|
||||
Drug Name |
Propan-2-one O-4-(hexyloxy)phenylcarbamoyl oxime
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [530604] | ||
Structure |
Download2D MOL |
||||
Formula |
C16H24N2O3
|
||||
Canonical SMILES |
CCCCCCOC1=CC=C(C=C1)NC(=O)ON=C(C)C
|
||||
InChI |
1S/C16H24N2O3/c1-4-5-6-7-12-20-15-10-8-14(9-11-15)17-16(19)21-18-13(2)3/h8-11H,4-7,12H2,1-3H3,(H,17,19)
|
||||
InChIKey |
OTUAPVMKCJEVBD-UHFFFAOYSA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Fatty-acid amide hydrolase | Target Info | Inhibitor | [530604] | |
BioCyc Pathway | Anandamide degradation | ||||
KEGG Pathway | Retrograde endocannabinoid signaling | ||||
PANTHER Pathway | Anandamide degradation | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.